Virtual briefing in partnership with Mergermarket, an Acuris company
DATE: 9 September 2020
TIME: 11:00 Beijing
Not only the cause for the most profound economic crisis since the Global Financial Crisis, but COVID-19 was also a wake-up call to better prepare for global pandemics and public health emergencies. After several years’ growth in the Greater China region, Healthcare and life science sector are firm back under the spotlight, as being one of the most resilient industries in investment and M&A.
In this live panel discussion with China Everbright, I-Mab and Fangda Partners we take stock of M&A and IPOs in Mainland China and consider the areas where financial stress is of greatest concern, as well as opportunities to be sought after.
Unable to join the live session? Register now to access the on-demand replay after the webinar.